Bolen, Joseph B.
Takeda Pharmaceutical Company Limited,
Japan
2025 Rank: 45281
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1768 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45281 | 50694 |
| Total Cites | 14656 | 15796 |
| H-index | 66 | 69 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 246 | 250 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1002 | 1020 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 4180 | 4421 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11398 | 11962 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.32 |
| Self-Citation Percentage |
7.22%
|
|
Bolen, Joseph B.
Takeda Pharmaceutical Company Limited,
United States
2024 Rank: 42269
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1743 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42269 | 46928 |
| Total Cites | 14267 | 15400 |
| H-index | 64 | 68 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 245 | 249 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 993 | 1012 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 4108 | 4350 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11073 | 11634 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.32 |
| Self-Citation Percentage |
7.36%
|
|
Bolen, Joseph B.
Takeda Pharmaceutical Company Limited,
United States
2023 Rank: 38467
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1659 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38467 | 42669 |
| Total Cites | 13943 | 15061 |
| H-index | 64 | 68 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 245 | 249 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 992 | 1011 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 4058 | 4294 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10796 | 11353 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
7.42%
|
|
Bolen, Joseph B.
Takeda Pharmaceutical Company Limited,
United States
2022 Rank: 34358
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1562 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34358 | 38283 |
| Total Cites | 13463 | 14570 |
| H-index | 64 | 68 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 245 | 249 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 982 | 1001 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 3971 | 4206 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10376 | 10926 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
7.60%
|
|
Bolen, Joseph B.
Takeda Pharmaceutical Company Limited,
United States
2021 Rank: 33118
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1502 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33118 | 37198 |
| Total Cites | 13193 | 14290 |
| H-index | 63 | 67 |
| Hm-index | 22 | 22 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 243 | 247 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 968 | 987 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 3916 | 4149 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10149 | 10694 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.34 |
| Self-Citation Percentage |
7.68%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.